1.Research Progress of in Vitro Experiment of Allergic Transfusion Reaction for Plasma Transfusion and Its Relative Mechanism---Review.
Chao-Yun XI ; Chun-Ya MA ; Hong-Fei ZHANG ; Chao WEI ; De-Qing WANG
Journal of Experimental Hematology 2021;29(5):1662-1666
Allergic transfusion reaction (ATR) caused by plasma transfusion is one of the main adverse transfusion reactions, and severe allergic reactions may even endanger the patient's life. Currently, ATR is mainly prevented and controlled by drug prevention and symptomatic treatment, and there still lack of preventive measures such as in vitro experiments. It has been shown that mast cells and basophils are the main effector cells of allergic reactions, and histamine is one of the main mediators of IgE-mediated allergic reactions. Some experiments can be used to identify patients with allergies or plasma components containing allergens, such as detection of serum-specific IgE, IgA, anti-IgA antibody, tryptase and histamine, mast cell degranulation test, basophil activation test, and so on. The basophil activation test can also be used for functional matching of plasma in vitro. Research of in vitro experiment of ATR is good for directing the precise infusion of plasma, reducing waste of resources, and avoiding the risk of blood transfusion. As a pre-transfusion laboratory test for clinical use, in vitro experiment of functional matching provides a new way to prevent ATR.
Blood Component Transfusion
;
Blood Transfusion
;
Humans
;
Hypersensitivity
;
Plasma
;
Transfusion Reaction
2.Steps taken to alleviate under-reporting of transfusion reactions at a public sector hospital in Pakistan.
Anila RASHID ; Mohammad Akbar AGHA ; Saima MINHAS ; Bipin NEPAL ; Nadeem NUSRAT
Blood Research 2016;51(4):290-292
No abstract available.
Pakistan*
;
Public Sector*
;
Transfusion Reaction*
3.Analysis of Related Factors of Adverse Transfusion Reactions.
Cong-Hai TANG ; Yan-Xue HUANG ; Yi-Xuan LIN ; Min YUAN
Journal of Experimental Hematology 2020;28(3):972-976
OBJECTIVE:
To investigate the related factors of adverse reactions of blood transfusion, and clinical precautions so as to reduce the adverse reactions.
METHODS:
Data of 2108 patients with allogeneic transfusion in our hospital from January 2017 to June 2017 collected and analyzed.
RESULTS:
These patients received 15 244 time of blood transfusion, and 213 time of adverse reactions occurred in 178 patients in totality, the incidence is 1.4%, and there was no significant difference between the male (1.31%) and female (1.53%). The main type of transfusion reaction were allergy (73.23%), FNHTR (11.74%) and TACO (10.80%). Among all kinds of blood components, the incidence of adverse reactions of apheresis platelet transfusion was the highest (4.31%), significantly higher than that of cryoprecipitate and other blood components. The incidence rate of adverse reactions of blood transfusion in the hematopathy patients was 2.56%, significantly higher than that of immune diseases (1.48%), cancer diseases (1.28%) and other diseases (1.08%), (P<0.01). The rate of transfusion history of apheresis platelets was 42.67% (the incidence of adverse reactions was 4.31%), significantly higher than other groups (P<0.01); the rate of transfusion history of cryoprecipitate was 4.11% (the incidence of adverse reaction was 0.45%), significantly lower than other groups (P<0.05). Among the disease types, the rate of transfusion history in the hematopathy patients was 48.79% (the incidence of adverse reaction was 2.56%), significantly higher than that of other groups (P<0.01). The incidence of drug allergy in patients with the adverse reactions to blood transfusion was 11.25%, significantly higher than that of patients without adverse reactions (4.71%) (P<0.01).
CONCLUSION
The main risk factors of adverse reactions of blood transfusion are as follows: blood varieties, disease type, transfusion history and drug allergy history. For the patients with transfusion, multiple factors should be controlled, so as to reduce the adverse reactions.
Blood Component Transfusion
;
Blood Transfusion
;
Female
;
Humans
;
Hypersensitivity
;
Male
;
Platelet Transfusion
;
Transfusion Reaction
4.Research advance on transfusion-related immunomodulation.
Journal of Experimental Hematology 2010;18(1):268-272
As allogeneic blood transfusion plays a role in clinical treatment effects, it also produces a number of immune-related side effects, such as the increased rate of postoperative infection, the rising relapse rate of malignant resection and so on. All those factors, such as CD200 surface molecule of allogeneic mononuclear cells, interleukin, sHLA and sFasL which are detached from the leukocyte surface during the period of storage, and serum bioactive molecules related to a certain degree with the occurrence of transfusion-related immunomodulation (TRIM). The clinical controlled trials, laboratory researches and animal models demonstrated that cloning deletion, induction of anergy and immune suppression are the three major mechanisms of TRIM. In this article, the research advances on mechanism of TRIM and the mediators inducing TRIM are reviewed.
Animals
;
Humans
;
Immunomodulation
;
Immunosuppression
;
Platelet Transfusion
;
adverse effects
;
Transfusion Reaction
5.Application Development of Blood Irradiation Indicator -Review.
Ke-Zhong SHEN ; Han-Hui XU ; Ming-Hui WANG
Journal of Experimental Hematology 2018;26(3):933-936
Transfusion-associated graft-versus-host disease (TA-GVHD) is known as one of common complications of blood transfusion. The blood irradiation is generally accepted as a proven method to prevent from this disease, for the reason that it makes lymphocytes inactivated in blood products. The blood irradiation indicator provides a guarantee of proper radiation dose, thus improving the transfusion safety. Though widely used in developed countries for decades, the blood irradiation indicator is still in the initial stage in our country. In this review, the action principle, applications and applied value of the blood irradiation indicator are summarized briefly.
Blood Transfusion
;
Graft vs Host Disease
;
Humans
;
Lymphocytes
;
Transfusion Reaction
6.Key Preparation Technique and Clinical Application of Frozen Platelets.
Guo-Liang DING ; Wei-Sheng QIN ; Lin-Yuan ZHAO ; Lin ZHU ; Yu-Fang BO ; Zhen LIU ; Jing-Han LIU
Journal of Experimental Hematology 2016;24(4):1226-1231
OBJECTIVETo explore the key technique for preparation of the frozen platelet and efficacy of its clinical application.
METHODSThe influences of the donators' peripheral platelet count, starting time of freeze, injection rate and evenness of the freeze-protective agent, storage mode, re-melting temperature and the capacity of water-bath etc. on the quality of the frozen platelets were analyzed retrospectively in 3 257 samples of frozen platelets before platelet pheresis. Then, the platelet counts were examined in 150 cases transfused with frozen platelets at the time-points of 1, 24, 48 and 72 hrs after transfusion, 90 cases suffered from the obstetrical bleeding were transfused with 200 parts of the re-melting frozen platelets, and then the peripheral blood platelet count, platelet increasing index(CCI), bleeding time and blood clot retraction rate etc. were observed for determining the clinical efficiency of the frozen platelets.
RESULTSThe floccule in the re-melting frozen platelets from the donators with (175-250)×10(9)/L platelets were decreased significantly(P<0.01). The quality of frozen platelets was influenced by the following factors, such as injection of DMSO at a too fast and heterogeneous rate, blood bags stored in a multilamminar space, and re-melting in a water-bath of small capacity etc. The routine storage for 0 and 3 days did not influence the quality of the frozen platelets. The recovery rate of one year-freezing platelets all was higher than 80%. The effects of the frozen platelets transfused into the patients with obstetrical bleeding displayed good haemostatic results, and the blood transfusion reaction did not occur. However, the frozen platelets immediately were exhausted and displayed their function, but the counting after 48 hrs could not display a good effect of raising platelet number.
CONCLUSIONSThe peripheral platelet count before platelet pheresis, the injection rate and evenness of the protective agent, the number of stratum for blood bags and the capacity of re-melting water-bath etc. all are the key factors influencing the quality of the frozen platelets. The frozen platelets prepared in this study shows a good efficacy of clinical application.
Blood Platelets ; Blood Preservation ; Blood Transfusion ; Freezing ; Hemostasis ; Humans ; Platelet Count ; Platelet Transfusion ; Plateletpheresis ; Transfusion Reaction
7.Correlation Analysis of Hemolytic Transfusion Reaction Induced by Low Titer Antibody.
Yuan-Yuan LUO ; Chun-Ya MA ; Li-Hui FU ; Xin YANG ; Yang YU ; De-Qing WANG
Journal of Experimental Hematology 2023;31(2):503-508
OBJECTIVE:
To establish the diagnostic process of low titer blood group antibody in the occurrence of adverse reactions of hemolytic transfusion.
METHODS:
Acid elusion test, enzyme method and PEG method were used for antibody identification. Combined with the patient's clinical symptoms and relevant inspection indexes, the irregular antibodies leading to hemolysis were detected.
RESULTS:
The patient's irregular antibody screening was positive, and it was determined that there was anti-Lea antibody in the serum. After the transfusion reaction, the low titer anti-E antibody was detected by enhanced test. The patient's Rh typing was Ccee, while the transfused red blood cells were ccEE. The new and old samples of the patient were matched with the transfused red blood cells by PEG method, and the major were incompatible. The evidence of hemolytic transfusion reaction was found.
CONCLUSION
Antibodies with low titer in serum are not easy to be detected, which often lead to severe hemolytic transfusion reaction.
Humans
;
Blood Transfusion
;
Transfusion Reaction/prevention & control*
;
Hemolysis
;
Blood Group Antigens
;
Erythrocyte Transfusion
;
Antibodies
;
Isoantibodies
;
Blood Group Incompatibility
8.Delayed Hemolytic Transfusion Reaction with Alloimmunization of Rh Phenotype: A Two-Case Study.
Dong Won YOO ; Hyun Ji LEE ; Sun Min LEE ; In Suk KIM ; Duyeal SONG ; Chulhun L CHANG ; Kyung Hwa SHIN ; Hyung Hoi KIM
Korean Journal of Blood Transfusion 2017;28(2):163-169
Delayed hemolytic transfusion reaction is difficult to prevent using an unexpected antibody test performed prior to transfusion, and unlike acute hemolytic transfusion reaction, it occurs a few days after blood transfusion. Hence, determining the reason for delayed hemolytic transfusion reaction may be a tim-consuming task for clinicians Here, we report our experience of two cases of delayed hemolytic transfusion reaction as a result of the unexpected antibody production to Rh blood group antigens after transfusion. The first patient with a history of transfusion during admission was identified as having anti-E and anti-C antibodies according to the antibody identification test at the time of re-admission. The second patient who had chronic blood transfusion due to cancer treatment was found to have anti-C antibody. Both patients received transfusion of Rh antigen-compatible RBC units only after unexpected antibody development. However, like both cases, patients receiving continuous blood transfusion should be considered for a routine Rh phenotype test.
Antibodies
;
Antibody Formation
;
Blood Group Antigens
;
Blood Transfusion
;
Humans
;
Phenotype*
;
Transfusion Reaction*
9.Two Clinical Cases of Anti-Di(b) with Di(a+b-) Phenotypes: Practical Need for Rare Blood Donor Registry Program in Korea.
Min Young LEE ; Tae Sung PARK ; Seung Hwan OH ; Sinyoung KIM ; Hyun Ok KIM
Laboratory Medicine Online 2017;7(2):79-82
Here, we report two cases of identified anti-Di(b) antibodies with rare Di(a+b−) blood types from two different hospitals in Korea. Di(b) mismatched transfusion could cause a hemolytic transfusion reaction. However, it is extremely difficult to find compatible blood for patients with such a rare blood type. In this regard, we concluded that national level rare donor registry program, wherein rare blood types are indexed, needs to be established. Moreover, laboratory medicine specialists at each hospital should encourage donor registration and family testing through education for helping patients with rare blood types. These efforts will help establish a system that guarantees safe blood transfusion for patients.
Antibodies
;
Blood Donors*
;
Blood Transfusion
;
Education
;
Humans
;
Korea*
;
Phenotype*
;
Specialization
;
Tissue Donors
;
Transfusion Reaction
10.A Case of Primary Anti-D Alloimmunization by RHD (c.1227G>A) DEL Red Blood Cell Transfusion.
Jung YOON ; Young Eun KOH ; Ha Nui KIM ; Jeeyong KIM ; Bo Kyeung JUNG ; Sun Ah LEE ; Deok Ja OH ; Chae Seung LIM
Korean Journal of Blood Transfusion 2016;27(2):169-173
The Rh blood group D antigen is the most immunogenic of all antigens, next to ABO antigens. Anti-D immunization is clinically important since it may cause clinical problems, such as severe hemolytic transfusion reactions and hemolytic disease of the newborn. DEL is an extremely weak D variant that cannot be detected by basic serologic typing and is typed as D-negative without the absorption-elution techniques and RHD genotyping. Of the DEL phenotype, RHD (c.1227G>A) allelic variant is the most common in Korea. The DEL phenotype has been considered to carry only a few D antigens to induce anti-D immunization, but a few cases have reported that this allelic variant is capable of inducing anti-D immunization in a D-negative recipient, for which it is clinical significant. Herein, we present a case of primary anti-D alloimmunization in a RhD negative patient after receiving RHD (c.1227G>A) DEL red cell transfusion identified by serological and molecular tests, including RHD genotyping.
Erythrocyte Transfusion*
;
Erythrocytes*
;
Humans
;
Immunization
;
Infant, Newborn
;
Korea
;
Phenotype
;
Transfusion Reaction